1) WHO, New vaccines against cervical cancer major opportunity for developing world, Press December, 2006
2) Wallin KL, Wiklund F, Angstrom T, et al:Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341:1633-1638, 1999
3) Herrero R, Hidesheim A, Bratti C, et al:A population-based study of human papillomavirus infection and all grades of cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 14:464-474, 2000
4) 石和久,喜納勝成,宇津野栄,他:ハイブリッドキャプチャー法によるHPV DNA検出キットのHPV感染症の診断における有用性.医学と薬学 39:849-853, 1998
in commercial sex workers in Japan. Infect Dis Obstet Gynecol 8:235-239, 2000
6) Ishi K, Suzuki F, Saito A, et al:Sexually transmitted disease among commercial sex workers in Japan, Sociaedad Iberoamericana de Information. www. siicsalud. com Article No.029/02606004, 2002
7) Ishi K, Suzuki F, Kina K, et al:Prevalence of human papillomavirus infection and correlation with cervical lesions in Japanese women. J Obstet Gynaecol Res 30:380-385, 2004
8) 笹川寿之:ヒト乳頭腫ウイルス感染症.産科と婦人科 67:1460-1468, 2000
9) Molano M, Posso H, Weiderpass E, et al:Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 87:324-333, 2002
10) Mroueh AM, Seoud MA, Kaspar HG, et al:Prevalence of genital human papillomavirus among Lebanese women. Eur J Gynaecol Oncol 23:429-432, 2002
11) Wreight TC, Schiffman M, Solomon D, et al:Interium guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet gynecol 103:304-309, 2004